Gilteritinib fumarate is the fumarate salt form of gilteritinib, an orally bioavailable inhibitor of receptor tyrosine kinases including FLT3, AXL, ALK, and LTK. It is used as an active pharmaceutical ingredient in manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1254053-84-3
Gilteritinib
active pharmaceutical ingredient
Rotigotine hydrochloride
active pharmaceutical ingredient
레디파스비르
hepatitis C NS5A inhibitor
N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
active pharmaceutical ingredient
Alectinib
active pharmaceutical ingredient
(E)-but-2-enedioic acid;bis(6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide)
UJOUWHLYTQFUCU-WXXKFALUSA-N
CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5.C(=C/C(=O)O)\C(=O)O